Mankind Pharma IPO: 10 things to know about the biggest issue so far this year
Indian pharma company Mankind Pharma is set to open its IPO next week. The offer for sale of 40 million equity shares by promoters and other existing shareholders is aiming to raise around INR4,326 crore ($523m). The price band has been set between INR1,026-1,080 per share, and subscriptions will be open to investors between 25 and 27 April with the shares likely to get listed on 9 May on both NSE and BSE
